株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血漿の世界市場:産業分析と展望

Global Blood Plasma Market: Industry Analysis & Outlook 2017-2021

発行 Koncept Analytics 商品コード 233439
出版日 ページ情報 英文 83 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.89円で換算しております。
Back to Top
血漿の世界市場:産業分析と展望 Global Blood Plasma Market: Industry Analysis & Outlook 2017-2021
出版日: 2017年04月26日 ページ情報: 英文 83 Pages
概要

当レポートでは、世界の血漿市場について調査分析し、主要な地域市場に焦点を当て、主要動向や発展、課題、競合情勢、主要企業プロファイルなど、体系的な情報を提供しています。

第1章 市場概要

  • 血漿
  • 血漿の派生物
  • 血漿の機能
  • 血漿の収集・抽出

第2章 血漿の世界市場の分析

  • 血漿市場の予測:金額別
  • 血漿分取容量の予測
  • 血漿市場:地域別
  • 血漿市場:区分別
  • 免疫グロブリン(Ig)の世界市場
    • 免疫グロブリン市場の予測:金額別
    • 免疫グロブリン市場の予測:数量別
    • 免疫グロブリン市場の規模:地域別
    • 免疫グロブリン市場:種類別
    • 免疫グロブリン治療人口:症状別
  • アブルミンの世界市場
    • アブルミン市場の予測:金額別
    • アブルミン市場の予測:数量別
    • アブルミン市場の規模:地域別
  • 血液凝固第VIII因子(Factor VIII)
    • 血液凝固第VIII因子市場の予測:金額別
    • 血液凝固第VIII因子市場の予測:数量別
    • 血液凝固第VIII因子市場:種類別

第3章 地域分析

  • 米国
    • 血漿市場:区分別
    • 免疫グロブリン市場の予測:金額別
    • 免疫グロブリン市場の予測:数量別
    • 免疫グロブリン市場の規模:区分別
    • 免疫グロブリン市場:特性別
    • アルブミン市場の予測:金額別
  • 中国
    • 血漿市場の予測:金額別
    • 血漿市場:区分別
    • アルブミン市場の予測:金額別
    • 免疫グロブリン市場の予測:金額別
    • 血液凝固第VIII因子市場の予測:金額別

第4章 市場力学

  • 市場動向
  • 成長促進要因
  • 市場の課題

第5章 競合環境

  • 血漿の世界市場
    • 血漿の市場シェア
    • 免疫グロブリンの市場シェア
    • アルブミンの市場シェア
    • 血漿由来の血液凝固第VIII因子の市場シェア
    • α1-アンチトリプシン(A1AT)の市場シェア
    • 血漿センター:企業別

第6章 企業プロファイル

  • Shire Plc.
  • CSL Limited
  • Grifols, S.A.
  • Octapharma, Inc.

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Plasma is obtained from blood after separation from red blood cells, white blood cells and platelets. The major components of blood plasma include proteins, amino acids, and other essential nutrients. Among these, proteins form the most important part of plasma and constitutes albumin, immunoglobulin, factor VIII, factor IX, alpha1 and many more. Plasma proteins are extracted from blood and used for many therapeutic indications.

Blood plasma is important because they fight off foreign substances that invade the body and transport nutrients and water. Plasma and recovered plasma are used to produce therapies that treat people with rare, chronic diseases and disorders such as primary immunodeficiency, hemophilia and genetic lung disease, as well as in the treatment of trauma, burns and shock. North America is the largest market for blood plasma as it has the most advanced infrastructure which has helped in increasing plasma collections over the time.

Growth factors of the global blood plasma market include increased diagnosis rate, rise in plasma collections and robust growth in emerging economies. Major trends of the market include increase in fractionation capacity, growing AATD market potential, and innovation in therapeutics. The market growth is hindered by factors such as high cost of treatment, lengthy approval process and high R&D costs.

The report offers an in-depth analysis of the global blood plasma market. It also covers global as well as regional aspect of the market. The report profiles the top notch players of the market including Shire Plc., CSL Limited, Grifols, S.A., and Octapharma Inc.

Table of Contents

1. Market Overview

  • 1.1. Blood Plasma
  • 1.2. Blood Plasma Derivatives
  • 1.3. Functions of Blood Plasma
  • 1.4. Plasma Collection

2. Global Market Analysis

  • 2.1. Global Blood Plasma Market Forecast by Value
  • 2.2. Global Blood Plasma Fractionation Capacity Forecast
  • 2.3. Global Blood Plasma Market by Region
  • 2.4. Global Blood Plasma Market by Segment
  • 2.5. Global Immunoglobulin Market
    • 2.5.1. Global Immunoglobulin Market Forecast by Value
    • 2.5.2. Global Immunoglobulin Market Forecast by Volume
    • 2.5.3. Global Immunoglobulin Market Volume by Region
    • 2.5.4. Global Immunoglobulin Market by Types
    • 2.5.5. Global Immunoglobulin Population by Indication
  • 2.6. Global Albumin Market
    • 2.6.1. Global Albumin Market Forecast by Value
    • 2.6.2. Global Albumin Market Forecast by Volume
    • 2.6.3. Global Albumin Market Volume by Region
  • 2.7. Global Factor VIII Market
    • 2.7.1. Global Factor VIII Market Forecast by Value
    • 2.7.2. Global Factor VIII Market Forecast by Volume
    • 2.7.3. Global Factor VIII Market by Type

3. Regional Analysis

  • 3.1. The US
    • 3.1.1. The US Blood Plasma Market by Segments
    • 3.1.2. The US Immunoglobulin Market Forecast by Value
    • 3.1.3. The US Immunoglobulin Market Forecast by Volume
    • 3.1.4. The US Immunoglobulin Market Volume by Segment
    • 3.1.5. The US Immunoglobulin Market by Specialty
    • 3.1.6. The US Albumin Market Forecast by Volume
  • 3.2. China
    • 3.2.1. China's Blood Plasma Market Forecast by Value
    • 3.2.2. China's Blood Plasma Market by Segments
    • 3.2.3. China's Albumin Market Forecast by Value
    • 3.2.4. China's Immunoglobulin Market Forecast by Value
    • 3.2.5. China's Factor VIII Market Forecast by Value

4. Market Dynamics

  • 4.1. Trends & Developments
    • 4.1.1. Increasing Fractionation Capacity
    • 4.1.2. Growing AATD Market Potential
    • 4.1.3. Innovation in Therapeutics Via Existing and New Proteins
  • 4.2. Growth Drivers
    • 4.2.1. Increased Diagnosis of Disease Treated by Immunoglobulin
    • 4.2.2. Increasing Plasma Collection
    • 4.2.3. Growing Blood Plasma Market in Emerging Economies
    • 4.2.4. Popularity of Albumin in Asian Countries
    • 4.2.5. Increasing Healthcare Expenditure
    • 4.2.6. Escalating Ageing Population
  • 4.3. Challenges & Issues
    • 4.3.1. High Cost of Treatment
    • 4.3.2. Unclear & Lengthy Process to Open Plasma Centre
    • 4.3.3. High R&D Costs

5. Competitive Landscape

  • 5.1. Global Market
    • 5.1.1. Global Blood Plasma Market Share
    • 5.1.2. Global Immunoglobulin Market Share
    • 5.1.3. Global Albumin Market Share
    • 5.1.4. Global Plasma-Derived Factor VIII Market Share
    • 5.1.5. Global Alpha1 Market Share
    • 5.1.6. Global Blood Plasma Centers by Major Players

6. Company Profiles

  • 6.1. Shire Plc.
    • 6.1.1. Business Overview
    • 6.1.2. Financial Overview
    • 6.1.3. Business Strategies
  • 6.2. CSL Limited
    • 6.2.1. Business Overview
    • 6.2.2. Financial Overview
    • 6.2.3. Business Strategies
  • 6.3. Grifols, S.A.
    • 6.3.1. Business Overview
    • 6.3.2. Financial Overview
    • 6.3.3. Business Strategies
  • 6.4. Octapharma, Inc.
    • 6.4.1. Business Overview
    • 6.4.2. Financial Overview
    • 6.4.3. Business Strategies

List of Charts

  • Components of Blood Plasma
  • Global Blood Plasma Market Forecast by Value (2016-2021)
  • Global Blood Plasma Fractionation Capacity Forecast (2016-2021)
  • Global Blood Plasma Market by Region (2016)
  • Global Blood Plasma Market by Segment (2016)
  • Global Immunoglobulin Market Forecast by Value (2016-2021)
  • Global Immunoglobulin Market Forecast by Volume (2016-2021)
  • Global Immunoglobulin Market Volume by Region (2016)
  • Global Immunoglobulin Market by Types (2016)
  • Global Immunoglobulin Population by Indication (2016)
  • Global Albumin Market Forecast by Value (2016-2021)
  • Global Albumin Market Forecast by Volume (2016-2021)
  • Global Albumin Market Volume by Region (2016)
  • Global Factor VIII Market Forecast by Value (2016-2021)
  • Global Factor VIII Market Forecast by Volume (2016-2021)
  • Global Factor VIII Market by Type (2016)
  • The US Blood Plasma Market by Segment (2016)
  • The US Immunoglobulin Market Forecast by Value (2016-2021)
  • The US Immunoglobulin Market Forecast by Volume (2016-2021)
  • The US Immunoglobulin Market Volume by Segment (2016)
  • The US Immunoglobulin Market by Specialty (2016)
  • The US Albumin Market Forecast by Volume (2016-2021)
  • China's Blood Plasma Market Forecast by Value (2016-2021)
  • China's Blood Plasma Market by Segments (2016)
  • China's Albumin Market Forecast by Value (2016-2021)
  • China's Immunoglobulin Market Forecast by Value (2016-2021)
  • China's Factor VIII Market Forecast by Value (2016-2021)
  • Global Alpha1 Patient Population (2016)
  • The US CIDP Market Opportunity (2016)
  • Plasma Collection in the US (2012-2016)
  • Albumin Consumption Per Capita by Country (2016)
  • Global Healthcare Expenditure (2012-2016)
  • Global Ageing Population of 60 Years or Older (2000-2030E)
  • Global Blood Plasma Market Share by Company (2016)
  • Global Immunoglobulin Market Share by Company (2016)
  • Global Albumin Market Share by Company (2016)
  • Global Plasma-Derived Factor VIII Market Share by Company (2016)
  • Global Alpha1 Market Share by Company (2016)
  • Global Blood Plasma Centers by Major Players (2016)
  • Shire Plc. Revenue Share by Franchise (2016)
  • Shire PLC's Revenue and Net Income (2012-2016)
  • CSL Limited's Revenue Share by Products (2016)
  • CSL Limited's Revenue and Net Profit (2012-2016)
  • Research & Development Investments of CSL Limited (2012-2016)
  • Grifols, S.A. Revenue Share by Business Segments (2016)
  • Grifols, S.A. Revenue and Gross Profit (2012-2016)
  • Octapharma, Inc. Revenue (2012-2016)
  • List of Tables
  • Blood Plasma Protein Breakup
  • Functions of Blood Plasma
  • Fractionation Capacity of Key Market Players (2013-2022E)
  • Therapeutic Products Under Development (2016)
  • Shire PLC's Major Product Approvals & Launches (2016)
  • Shire PLC's Major Product Pipeline (2016)
  • CSL Ltd.'s Major Product Development (2016)
Back to Top